Lewis Levy Sells 2,025 Shares of Teladoc Health Inc (NYSE:TDOC) Stock

Teladoc Health Inc (NYSE:TDOC) insider Lewis Levy sold 2,025 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $84.00, for a total value of $170,100.00. Following the completion of the transaction, the insider now directly owns 5,655 shares in the company, valued at $475,020. The sale was disclosed in a document filed with the SEC, which is accessible through this link.

Lewis Levy also recently made the following trade(s):

  • On Monday, December 2nd, Lewis Levy sold 2,025 shares of Teladoc Health stock. The stock was sold at an average price of $80.50, for a total value of $163,012.50.
  • On Tuesday, October 15th, Lewis Levy sold 675 shares of Teladoc Health stock. The stock was sold at an average price of $70.00, for a total value of $47,250.00.

TDOC stock opened at $94.79 on Thursday. Teladoc Health Inc has a fifty-two week low of $48.57 and a fifty-two week high of $98.97. The stock has a market capitalization of $7.01 billion, a P/E ratio of -65.83 and a beta of 1.38. The business has a 50-day moving average of $82.71 and a 200-day moving average of $72.24. The company has a debt-to-equity ratio of 0.44, a current ratio of 6.55 and a quick ratio of 6.55.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings data on Wednesday, October 30th. The health services provider reported ($0.28) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.40) by $0.12. The company had revenue of $137.96 million during the quarter, compared to analysts’ expectations of $136.46 million. Teladoc Health had a negative return on equity of 11.23% and a negative net margin of 20.15%. The business’s revenue was up 24.3% on a year-over-year basis. During the same period last year, the firm posted ($0.34) earnings per share. Equities analysts expect that Teladoc Health Inc will post -1.55 EPS for the current year.

A number of institutional investors have recently bought and sold shares of the business. CNB Bank boosted its holdings in shares of Teladoc Health by 100.0% during the 3rd quarter. CNB Bank now owns 400 shares of the health services provider’s stock valued at $27,000 after acquiring an additional 200 shares in the last quarter. Capital Investment Advisory Services LLC increased its holdings in Teladoc Health by 800.0% during the 3rd quarter. Capital Investment Advisory Services LLC now owns 450 shares of the health services provider’s stock worth $30,000 after purchasing an additional 400 shares in the last quarter. Quadrant Capital Group LLC boosted its stake in shares of Teladoc Health by 32.4% in the 3rd quarter. Quadrant Capital Group LLC now owns 621 shares of the health services provider’s stock worth $41,000 after buying an additional 152 shares during the last quarter. Marshall Wace North America L.P. purchased a new position in shares of Teladoc Health in the 1st quarter worth approximately $35,000. Finally, American National Bank bought a new position in Teladoc Health in the third quarter valued at $54,000.

A number of analysts have recently issued reports on TDOC shares. Zacks Investment Research cut Teladoc Health from a “buy” rating to a “hold” rating and set a $89.00 price objective on the stock. in a research report on Wednesday, November 27th. Credit Suisse Group boosted their price objective on Teladoc Health from to in a research report on Monday. SunTrust Banks reaffirmed a “hold” rating and issued a $80.00 price target on shares of Teladoc Health in a research note on Monday, December 2nd. Jefferies Financial Group lowered Teladoc Health from a “buy” rating to a “hold” rating and set a $80.00 price target on the stock. in a research note on Friday, December 6th. Finally, Stifel Nicolaus began coverage on Teladoc Health in a research note on Monday, November 25th. They issued a “hold” rating and a $83.00 price target on the stock. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus target price of $87.71.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Read More: Risk Tolerance

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News